| 000 | 01691 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513102129.0 | ||
| 264 | 0 | _c19961231 | |
| 008 | 199612s 0 0 eng d | ||
| 022 | _a0269-9370 | ||
| 024 | 7 |
_a10.1097/00002030-199610090-00007 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKuritzkes, D R | |
| 245 | 0 | 0 |
_aDrug resistance and virologic response in NUCA 3001, a randomized trial of lamivudine (3TC) versus zidovudine (ZDV) versus ZDV plus 3TC in previously untreated patients. _h[electronic resource] |
| 260 |
_bAIDS (London, England) _cAug 1996 |
||
| 300 |
_a975-81 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xpharmacology |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Resistance |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenes, Viral |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHIV-1 _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLamivudine _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMutation _xdrug effects |
| 650 | 0 | 4 | _aVirus Replication |
| 650 | 0 | 4 |
_aZidovudine _xpharmacology |
| 700 | 1 | _aQuinn, J B | |
| 700 | 1 | _aBenoit, S L | |
| 700 | 1 | _aShugarts, D L | |
| 700 | 1 | _aGriffin, A | |
| 700 | 1 | _aBakhtiari, M | |
| 700 | 1 | _aPoticha, D | |
| 700 | 1 | _aEron, J J | |
| 700 | 1 | _aFallon, M A | |
| 700 | 1 | _aRubin, M | |
| 773 | 0 |
_tAIDS (London, England) _gvol. 10 _gno. 9 _gp. 975-81 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00002030-199610090-00007 _zAvailable from publisher's website |
| 999 |
_c8847896 _d8847896 |
||